Rush University Medical Center

Early Predictor of Severe Respiratory Failure in Patients With COVID-19 Identified

Findings published in Critical Care suggest that high plasma levels of the protein suPAR are associated with worse outcomes

Newswise — A very high level of a protein known as suPAR in the blood of patients with COVID-19 may be a predictor of severe respiratory failure, according to new research published in the Journal of Critical Care on April 30. The findings by researchers at Rush University Medical Center and other institutions suggest suPAR could be a potential predictor for which patients with COVID-19 will need to be put on ventilators to help them breathe.

“This is the first report in the world to show that suPAR is elevated in COVID-19 and is predictive. Since suPAR is a reactant of the innate immune system, it’s an indicator of disease severity,” said Jochen Reiser, MD, PhD, the Ralph C. Brown, MD, Professor of Internal Medicine, chairperson of the Department of Internal Medicine at Rush.

“These results show that the higher the plasma suPAR level, the worse the outcome will be in the lungs of these patients,” said Reiser, who is co-correspondent author of the study. “The higher the suPAR level, the shorter the time before patients needed intubation.”

Reiser’s research team tested suPAR levels in 15 Rush patients when they were admitted or tested for COVID-19. The University of Athens Medical School measured 57 patients for suPAR and followed them in their clinical course. Time to intubation was followed and found to be shorter in patients with a higher plasma suPAR.

“There is a body of literature that suPAR is associated with poor outcomes from acute respiratory distress syndrome (a condition in many patients with severe COVID-19) and poor lung functioning in critically ill patients,” Reiser said.

Reiser also mentions that the link between suPAR and respiratory failure suggests a way to help manage patients with COVID-19.

“If we measure suPAR as part of diagnosing COVID-19, we may know whom to watch more and whom to send home,” he said. “Plasma suPAR levels give us a window into the course of the disease, allowing for an improved monitoring and applying new and supportive treatments early.” 

The findings of the present research raise additional new questions about a role for suPAR in COVID-19-associated organ dysfunction.

Soluble urokinase plasminogen activator receptor, aka suPAR, is produced in the endobronchial tree in the lungs and by immune cells in the bone marrow and repeatedly has been shown to harm kidneys. In two publications in The New England Journal of Medicine, Reiser’s research showed that chronically elevated blood levels are linked to development of chronic kidney disease, yet a high plasma suPAR also increases the risk for acute kidney injury – a sudden decline in kidney function that can be a severe side effect of general medical procedures.

Reportedly, an increasing number of patients with severe COVID-19 also develop kidney problems, which is leading researchers to investigate the connection between COVID-19, suPAR and kidney disease.

“Our research on suPAR and COVID-19 associated lung injury is based on a small sample size, and we will need more data, but the findings support a concept that suPAR is harmful in COVID-19. It may therefore play a prognostic and a causal role in COVID-19 associated kidney disease, Reiser said.”

Funding for this work was provided by unrestricted educational grants by the Hellenic Institute for the Study of Sepsis. Funds were also provided by Rush University Medical Center.

 




Filters close

Showing results

110 of 2484
Released: 7-Jul-2020 5:25 PM EDT
Lung physiology and immune function in children could be protecting them from severe COVID-19
University of Texas Health Science Center at Houston

Differences in lung physiology and immune function in children could be why they are more often spared from severe illness associated with COVID-19 than adults, according to pediatric and adult physicians at UTHealth and Baylor College of Medicine, who teamed up to investigate the disparity.

access_time Embargo lifts in 2 days
Embargo will expire: 8-Jul-2020 8:30 AM EDT Released to reporters: 7-Jul-2020 5:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 8-Jul-2020 8:30 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: ACI Launches “Healthy Returns”: New Toolkit Contains Important Cleaning, Hygiene Reminders for Reopened Businesses and Offices
Released: 7-Jul-2020 5:15 PM EDT
ACI Launches “Healthy Returns”: New Toolkit Contains Important Cleaning, Hygiene Reminders for Reopened Businesses and Offices
American Cleaning Institute

As communities across the nation begin the reopening process stemming from the coronavirus (COVID-19) pandemic, the American Cleaning Institute (ACI) announced the roll-out of Healthy Returns, a free online toolkit for small businesses and offices containing concise, easy to understand reminders on hygiene, cleaning and disinfecting that are crucial to keeping the workplace healthy and safe.

access_time Embargo lifts in 2 days
Embargo will expire: 10-Jul-2020 1:00 AM EDT Released to reporters: 7-Jul-2020 3:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 10-Jul-2020 1:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 7-Jul-2020 2:45 PM EDT
COVID-19 in Patients Who Have Received Kidney Transplants or Are Undergoing Dialysis
American Society of Nephrology (ASN)

• A recent study found that most kidney transplant recipients with COVID-19 do not need to be hospitalized. • Another study found that patients on dialysis who develop COVID-19 may have symptoms that are different from other patients with the infectious disease.

Released: 7-Jul-2020 2:05 PM EDT
Law clinic wins access to COVID-19 race data
Cornell University

The First Amendment Clinic at Cornell Law School, working on behalf of its client, The New York Times, helped secure the release of previously unseen data that provides the most detailed look yet at nearly 1.5 million American coronavirus patients from 974 counties across the country.

Newswise: Welcome, Robin the AI robot
Released: 7-Jul-2020 2:05 PM EDT
Welcome, Robin the AI robot
University of California, Los Angeles (UCLA), Health Sciences

In response to the COVID-19 pandemic, UCLA Mattel Children’s Hospital launched an innovative project to support the emotional needs of children through a new AI powered robot. Robin’s technology enables the robot to build what is called associative memory — it recognizes a child’s emotions by interpreting his or her facial expressions and builds responsive dialogue by replicating patterns formed from previous experiences.

Released: 7-Jul-2020 2:00 PM EDT
Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors (PPIs)
American College of Gastroenterology (ACG)

Findings from an online survey of more than 53,000 American adults suggest that using heartburn medications known as proton pump inhibitors (PPIs) once or twice daily significantly increases the odds of a positive test for COVID-19 compared to those who do not take PPIs. This research appeared online July 7, 2020 in pre-print format in The American Journal of Gastroenterology.

Released: 7-Jul-2020 1:40 PM EDT
COVID-related discrimination disproportionately impacts racial minorities, study shows
University of Southern California (USC)

Discrimination against people thought to be infected with coronavirus was experienced by a rising number of United States residents, particularly racial minorities, in the early stages of the COVID-19 pandemic, according to a new study from the USC Dornsife College of Letters, Arts and Sciences.

Newswise: 236726_web.jpg
Released: 7-Jul-2020 1:10 PM EDT
A chemical cocktail of air pollution in Beijing, China during COVID-19 outbreak
Institute of Atmospheric Physics, Chinese Academy of Sciences

The novel coronavirus disease (COVID-19) spreads rapidly around the world, and has limited people's outdoor activities substantially.


Showing results

110 of 2484

close
1.96488